Marc L. Turner

3.0k total citations
54 papers, 1.6k citations indexed

About

Marc L. Turner is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Marc L. Turner has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Hematology and 17 papers in Immunology. Recurrent topics in Marc L. Turner's work include Complement system in diseases (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and CAR-T cell therapy research (8 papers). Marc L. Turner is often cited by papers focused on Complement system in diseases (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and CAR-T cell therapy research (8 papers). Marc L. Turner collaborates with scholars based in United Kingdom, Japan and United States. Marc L. Turner's co-authors include Andrejs Ivanovs, Alexander Medvinsky, Richard A. Anderson, Stanislav Rybtsov, David C. Kilpatrick, Lindsey Welch, G R Barclay, Christopher A. Ludlam, A. C. Parker and Anne Atkinson and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Science Translational Medicine.

In The Last Decade

Marc L. Turner

52 papers receiving 1.6k citations

Peers

Marc L. Turner
Simin Saffaripour United States
Takashi Hiroyama Japan
Tamihiro Kamata United Kingdom
Michihiro Hidaka Japan
Kathleen Tomkinson United States
DA Williams United States
François Mercier Canada
Lucia Dora Notarangelo Italy
Tessa Kerre Belgium
Mamiko Sakata‐Yanagimoto Japan
Simin Saffaripour United States
Marc L. Turner
Citations per year, relative to Marc L. Turner Marc L. Turner (= 1×) peers Simin Saffaripour

Countries citing papers authored by Marc L. Turner

Since Specialization
Citations

This map shows the geographic impact of Marc L. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc L. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc L. Turner more than expected).

Fields of papers citing papers by Marc L. Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc L. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc L. Turner. The network helps show where Marc L. Turner may publish in the future.

Co-authorship network of co-authors of Marc L. Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Marc L. Turner. A scholar is included among the top collaborators of Marc L. Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc L. Turner. Marc L. Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Rachel, Linda Smith, Graeme Cowan, et al.. (2024). EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation. Frontiers in Immunology. 15. 1412211–1412211. 2 indexed citations
2.
Maiers, Martin, et al.. (2024). Harnessing global HLA data for enhanced patient matching in iPSC haplobanks. Cytotherapy. 27(3). 300–306. 2 indexed citations
3.
Cooper, Rachel, Gwen Wilkie, Mark A. Vickers, et al.. (2021). Cytometric analysis of T cell phenotype using cytokine profiling for improved manufacturing of an EBV-specific T cell therapy. Clinical & Experimental Immunology. 206(1). 68–81. 3 indexed citations
4.
Brennan, Paul, Mark T. Macmillan, Catriona Graham, et al.. (2021). Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). BMJ Open. 11(11). e053190–e053190. 25 indexed citations
5.
Forbes, Shareen, Andrew Bond, Paul S. Burgoyne, et al.. (2020). Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization. Science Translational Medicine. 12(526). 42 indexed citations
6.
Sullivan, Stephen, Patrick Ginty, Susan L. Solomon, et al.. (2020). The Global Alliance for iPSC Therapies (GAiT). Stem Cell Research. 49. 102036–102036. 21 indexed citations
7.
Sullivan, Stephen, Paul J. Fairchild, Steven G. E. Marsh, et al.. (2020). Haplobanking induced pluripotent stem cells for clinical use. Stem Cell Research. 49. 102035–102035. 38 indexed citations
8.
Ivanovs, Andrejs, Stanislav Rybtsov, Richard A. Anderson, Marc L. Turner, & Alexander Medvinsky. (2014). Identification of the Niche and Phenotype of the First Human Hematopoietic Stem Cells. Stem Cell Reports. 2(4). 449–456. 73 indexed citations
9.
Mittra, James, et al.. (2014). Identifying viable regulatory and innovation pathways for regenerative medicine: a case study of cultured red blood cells. New Biotechnology. 32(1). 180–190. 22 indexed citations
10.
Cuesta, Jesús de Pedro, María Ruiz-Tovar, Helen Ward, et al.. (2012). Sensitivity to Biases of Case-Control Studies on Medical Procedures, Particularly Surgery and Blood Transfusion, and Risk of Creutzfeldt-Jakob Disease. Neuroepidemiology. 39(1). 1–18. 20 indexed citations
11.
Ivanovs, Andrejs, Stanislav Rybtsov, Lindsey Welch, et al.. (2011). Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. The Journal of Experimental Medicine. 208(12). 2417–2427. 187 indexed citations
12.
Tura-Ceide, Olga, Jeffrey D. Crawford, G R Barclay, et al.. (2010). Granulocyte colony‐stimulating factor (G‐CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy. Journal of Thrombosis and Haemostasis. 8(7). 1614–1623. 23 indexed citations
13.
Cedzyński, Maciej, Anne Atkinson, Anna S. Świerzko, et al.. (2009). L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children. Molecular Immunology. 47(2-3). 415–419. 48 indexed citations
14.
Świerzko, Anna S., Anne Atkinson, Maciej Cedzyński, et al.. (2008). Two factors of the lectin pathway of complement, l-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates. Molecular Immunology. 46(4). 551–558. 55 indexed citations
15.
Tura-Ceide, Olga, G R Barclay, Huw Roddie, John Davies, & Marc L. Turner. (2007). Optimal ex vivo expansion of neutrophils from PBSC CD34+ cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO. Journal of Translational Medicine. 5(1). 53–53. 21 indexed citations
16.
Tura-Ceide, Olga, G R Barclay, Huw Roddie, John Davies, & Marc L. Turner. (2007). Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources. Journal of Translational Medicine. 5(1). 37–37. 22 indexed citations
17.
Paterson, Trevor, et al.. (2000). Gene Transfer to Primary Acute Myeloid Leukaemia Blasts and Myeloid Leukaemia Cell Lines. PubMed. 6(3). 127–134. 21 indexed citations
18.
Barclay, G R, James Hope, Christopher R. Birkett, & Marc L. Turner. (1999). Distribution of cell‐associated prion protein in normal adult blood determined by flow cytometry. British Journal of Haematology. 107(4). 804–814. 61 indexed citations
19.
20.
Turner, Marc L., et al.. (1993). Subclinical autonomic dysfunction in patients with Hodgkin's disease and non‐Hodgkin's lymphoma. British Journal of Haematology. 84(4). 623–626. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simin Saffaripour Breakdown of academic impact, for papers by Takashi Hiroyama Breakdown of academic impact, for papers by Tamihiro Kamata Breakdown of academic impact, for papers by Michihiro Hidaka Breakdown of academic impact, for papers by Kathleen Tomkinson Breakdown of academic impact, for papers by DA Williams Breakdown of academic impact, for papers by François Mercier Breakdown of academic impact, for papers by Lucia Dora Notarangelo Breakdown of academic impact, for papers by Tessa Kerre Breakdown of academic impact, for papers by Mamiko Sakata‐Yanagimoto
Rankless by CCL
2026